ANURAG GUPTA: Open Payments
NPI 1144285552 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,243 in 55 payments from 17 companies in 2025. Trend: 2023 $329 · 2024 $1,196 · 2025 $1,243
Food & beverage: $1,243
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 11 | $237 |
| Otsuka America Pharmaceutical, Inc. | 9 | $202 |
| ABBVIE INC. | 7 | $142 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $91 |
| Alkermes, Inc. | 3 | $80 |
| Almatica Pharma LLC | 3 | $70 |
| Tris Pharma Inc | 3 | $67 |
| Bausch Health US, LLC | 3 | $61 |
| Axsome Therapeutics, Inc. | 2 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $52 |
Products named: FANAPT, REXULTI, VRAYLAR, TRINTELLIX, ARISTADA, LOREEV XR, Dyanavel XR, APLENZIN.
Industry payments across NV — which companies pay providers there.
